Boston Scientific Corporation Detailed Financials

Full historical quarterly statements

Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue5.44B5.20B5.29B5.07B5.06B4.66B4.56B4.21B
Cost of Goods Sold1.59B1.59B1.35B1.52B1.64B1.71B1.89B1.56B
Gross Profit3.85B3.61B3.94B3.54B3.42B2.95B2.67B2.65B
R&D Expenses554.0M516.0M569.0M514.0M526.0M443.0M460.0M407.0M
Operating Expenses2.67B2.54B2.73B2.49B2.60B2.05B2.08B1.97B
Operating Income1.18B1.07B1.21B1.05B819.0M896.0M589.0M674.0M
Other Income / Gains-118.0M90.0M-506.0M-111.0M122.0M-91.0M-4.0M-6.0M
Net Income907.0M1.34B668.0M755.0M793.0M674.0M566.0M469.0M
EPS (Diluted)0.620.900.450.510.540.4560.3840.319
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.7070.6940.7450.6990.6770.6330.5860.629
General And Administrative Expenses00000000
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses1.80B1.78B1.83B1.74B1.72B1.60B1.61B1.56B
Other Expenses313.0M244.0M328.0M237.0M363.0M14.0M10.0M5.0M
Cost And Expenses4.26B4.13B4.08B4.01B4.24B3.77B3.97B3.54B
Interest Income00000022.0M0
Interest Expense96.0M90.0M90.0M87.0M90.0M87.0M139.0M83.0M
Depreciation And Amortization233.0M351.0M365.0M342.0M336.0M325.0M348.0M307.0M
Ebitda1.39B1.60B1.32B1.37B1.37B1.22B1.07B1.06B
Ebitdaratio0.2550.3080.250.270.270.2610.2350.251
Operating Income Ratio0.2160.2060.2280.2070.1620.1920.1290.16
Income Before Tax1.06B1.16B700.0M939.0M941.0M805.0M585.0M668.0M
Income Before Tax Ratio0.1950.2230.1320.1850.1860.1730.1280.159
Income Tax Expense155.0M-176.0M31.0M183.0M146.0M133.0M23.0M200.0M
Net Income Ratio0.1670.2570.1260.1490.1570.1450.1240.111
Epsdiluted0.610.900.450.500.530.4510.380.315
Weighted Average Shs Out1.48B1.48B1.48B1.48B1.48B1.48B1.47B1.47B
Weighted Average Shs Out Dil1.48B1.50B1.50B1.50B1.49B1.49B1.49B1.49B